Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (2,200,176) $ (2,562,743)  
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation expense 525,229 354,503  
Amortization expense 367,500  
Amortization of debt discount 2,040,000 236,364  
Change in fair value of derivative liability (1,314,000)  
Change in fair value of warrant liability (1,915,000) $ 1,987,000
Financing costs 109,953  
Forgiveness of PPP loan (103,200)  
Shares issued for services 24,375 73,651  
Changes in operating assets and liabilities:      
Accounts receivable (24,132)  
Inventory (35,368)  
Prepaid expenses and other current assets (481,750) 76,500  
Accounts payable 450,606 (304,997)  
Other accrued expenses 11,140 (33,836)  
Accrued interest 488,797 13,018  
Accrued interest - related parties 8,275  
Cash used in operating activitites (2,054,504) (2,140,787)  
CASH FLOWS FROM INVESTING ACTIVITIES      
Cash paid for machinery and equipment (491,112) (411,293)  
Cash paid for patent acquisition with F & T (2,000,000)  
Cash paid for acquisition of shares of NCI (1,000,000)  
Cash paid for construction in process (749,651)  
CASH USED IN INVESTING ACTIVITIES (491,112) (4,160,944)  
CASH FLOWS FROM FINANCING ACTIVITIES      
Payments on bank loan (2,042)  
Payments of notes payable (24,000) (24,000)  
Payments on notes payable, related party (655,750)  
Repayment of short-term promissory note and lines of credit (552,788)  
Proceeds from issuance of common shares under equity agreeement 17,277,123  
Proceeds from convertible debentures, receipt from escrow 1,500,000  
Payments on  convertible debentures (421,486)  
Redemption of Series D PS (3,513,504)  
Shares issued upon exercise of warrants 11,000  
Cash provided by financing activitites 1,476,000 12,118,553  
NET CHANGE IN CASH (1,069,616) 5,816,822  
CASH AT BEGINNING OF YEAR 1,734,040 155,795 155,795
CASH AT END OF YEAR 664,424 5,972,617 $ 1,734,040
INTEREST PAID 5,300 81,536  
Supplemental Disclosure of Non-Cash Investing and Financing Activities:      
Construction in process transferred to fixed assets 1,040,617  
Shares issued upon conversion of convertible debentures 421,486  
Shares issued upon conversion of Preferred stock 840,000  
Cancellation of Right of Use asset and Lease liability 275,400  
Shares issued as consideration for Patent acquisition 5,000,000  
Shares issued as consideration for acquisition of remaining NCI $ 2,000,000